Uveitis clinical trials
The registry lists 334 studies for Uveitis across more than 10 countries. 38 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 185
- Status unknown
- 41
- Terminated
- 39
- Recruiting
- 25
- Active, not recruiting
- 16
- Withdrawn
- 14
Phase
- Phase 2
- 82
- Phase 3
- 66
- Phase 1
- 39
- Phase 4
- 31
- Early Phase 1
- 1
Where
- United States
- 158
- Germany
- 39
- United Kingdom
- 38
- France
- 37
- China
- 30
- India
- 21
Who runs them
National Eye Institute (NEI) (41) · Assistance Publique - Hôpitaux de Paris (9) · Novartis Pharmaceuticals (9) · St. Franziskus Hospital (9) · Oregon Health and Science University (6) · Duke University (6) · University of California, San Francisco (5) · Allergan (5)
Studies
Recruiting first, then most recently updated. Showing 50 of 334 — search for more.
- PANDA-ASOCT: Paediatric Anterior Uveitis Detection With Automated Image Analysis Using ASOCTRecruitingNCT078135981 country
- A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.RecruitingNCT07547995Phase 21 country
- Metagenomics for Ocular InflammationRecruitingNCT069741621 country
- Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic UveitisNot yet recruitingNCT06390436Phase 41 country
- Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome PatientsRecruitingNCT06395285Phase 13 countries
- A Study of Uveitis in Children <18 Years of AgeRecruitingNCT075181341 country
- A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIURecruitingNCT07552012Phase 21 country
- RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric AgeRecruitingNCT062737485 countries
- Genetics of UveitisRecruitingNCT023572381 country
- Analysis of Anterior Chamber Inflammation by Optical Coherence TomographyRecruitingNCT017465371 country
- A Proof-of-concept Trial to EvaluAte the efficaCy and Safety Of Cell Therapy TRX103 in Patients With Active, Non-infectious UveitisNot yet recruitingNCT07427628Phase 11 country
- Wide Field OCTA in Ocular DiseasesNot yet recruitingNCT07298174
- The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior SegmentRecruitingNCT05486468Phase 31 country
- AutoInflammatory Disease Alliance Registry (AIDA)RecruitingNCT0520071522 countries
- Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION StudyRecruitingNCT06161415Phase 11 country
- Role of OCT & OCT Angiography in Patients With Posterior at the Uveitis Clinic of Assiut University Hospital.Not yet recruitingNCT06743906
- Demographic Data and Clinical Presentation of Pediatric UveitisNot yet recruitingNCT06920017
- Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious UveitisRecruitingNCT02706704Phase 21 country
- Observational Prospective Turkish Inception Cohort of Uveitis and SpondyloarthritisRecruitingNCT067203761 country
- Efficacy and Safety of Tofacitinib in Refractory Blau SyndromeEnrolling by invitationNCT06660329Phase 41 country
- Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.RecruitingNCT06539481Phase 43 countries
- A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious UveitisRecruitingNCT055927171 country
- Lyon Sarcoid Uveitis CohortRecruitingNCT038637821 country
- Lyon Uveitis StudyRecruitingNCT038775751 country
- Chinese Spondyloarthritis Inception Cohort (CESPIC)Not yet recruitingNCT05960864
- Imaging Based Uveitis Screening for Children With Juvenile Idiopathic ArthritisNot yet recruitingNCT05984758Not applicable1 country
- Proportion of Clinical Improvement & Type 1 Interferon (IFN) Score Changes in Idiopathic Uveitis Patients With Interferon Gamma Release Assay (IGRA) PositiveRecruitingNCT040880191 country
- Treatment FOr Corticosteroid Dependent UveitiSNot yet recruitingNCT06258915Phase 3
- Optical Coherence Tomography (OCT) in UveitisRecruitingNCT020261281 country
- Relevance and Efficiency of SecOnd Line Workup for UveitisNot yet recruitingNCT06102408
- Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept StudyRecruitingNCT06085079Phase 41 country
- Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior UveitisRecruitingNCT04798755Phase 31 country
- Prospective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiSNot yet recruitingNCT05928754Not applicable
- "Comparison of the Efficacy and Safety of Adalimumab to That of Tocilizumab in Severe Uveitis of Behçet's Disease"Not yet recruitingNCT05874505Phase 2
- Minocycline for Chronic Autoimmune UveitisRecruitingNCT05474729Phase 1/21 country
- Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's UveitisNot yet recruitingNCT05105347Phase 4
- German Spondyloarthritis Inception CohortRecruitingNCT012774191 country
- Acute and Chronic Inflammatory Disease, Lifestyle and Treatment ResponseRecruitingNCT041930201 country
- The Cohort Study of Uveitis PatientsCompletedNCT057275401 country
- Intestinal Bacteria and Ocular Inflammatory DiseaseCompletedNCT018592991 country
- Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious UveitisCompletedNCT06310837Not applicable1 country
- Screening for Oculocerebral Lymphoma With the Phenotype of NK Cells in Patients With UveitisCompletedNCT05388838Not applicable1 country
- Uveitis/Intraocular Inflammatory Disease Biobank (iBank)CompletedNCT026563811 country
- An Interventional Study of Upadacitinib Extended-Release Tablets in Patients With Refractory UveitisActive, not recruitingNCT07773623Phase 41 country
- A Study of REGN7041 for Active Noninfectious Uveitis in Adult ParticipantsTerminatedNCT07218770Phase 1/21 country
- Ocular Pathogen and Transcriptome Investigation Using Comprehensive SequencingCompletedNCT05286203Not applicable1 country
- A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive UveitisActive, not recruitingNCT04088409Phase 35 countries
- Imaging Quantification of Inflammation (IQI)Active, not recruitingNCT047046091 country
- Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide ImplantCompletedNCT043405051 country
- Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)CompletedNCT03841357Phase 31 country